Original Source(s)
Related Content
FDA Approves Expanded Liquid Biopsy Panel
Updated liquid biopsy combines genomic and epigenomic profiling for companion diagnostic use across multiple tumor types.
May 20, 2026
-
2 min
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min